Literature DB >> 22538529

Preformulation characterization of an aluminum salt-adjuvanted trivalent recombinant protein-based vaccine candidate against Streptococcus pneumoniae.

Vidyashankara Iyer1, Lei Hu, Mangala Roshan Liyanage, Reza Esfandiary, Christoph Reinisch, Andreas Meinke, Jeff Maisonneuve, David B Volkin, Sangeeta B Joshi, C Russell Middaugh.   

Abstract

The preformulation of a trivalent recombinant protein-based vaccine candidate for protection against Streptococcus pneumoniae is described both in the presence and in the absence of aluminum salt adjuvants. The biophysical properties of the three protein-based antigens, fragments of pneumococcal surface adhesion A (PsaA), serine-threonine protein kinase (StkP), and protein required for cell wall separation of group B streptococcus (PcsB), were studied using several spectroscopic and light scattering techniques. An empirical phase diagram was constructed to assess the overall conformational stability of the three antigens as a function of pH and temperatures. A variety of excipients were screened on the basis of their ability to stabilize each antigen using intrinsic fluorescence spectroscopy and circular dichroism spectroscopy. Sorbitol, sucrose, and trehalose stabilized the three proteins in solution. The addition of manganese also showed a drastic increase in the thermal stability of SP1650 in solution. The adsorption and desorption processes of each of the antigens to aluminum salt adjuvants were evaluated, and the stability of the adsorbed proteins was then assessed using intrinsic fluorescence spectroscopy and Fourier transform infrared spectroscopy. All the three proteins showed good adsorption to Alhydrogel. PsaA was destabilized when adsorbed onto Alhydrogel® and adding sodium phosphate showed a stabilizing effect. PcsB was found to be stabilized when adsorbed to Alhydrogel®, and no destabilizing or stabilizing effects were seen in the case of StkP.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22538529     DOI: 10.1002/jps.23175

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  9 in total

1.  Improved data visualization techniques for analyzing macromolecule structural changes.

Authors:  Jae Hyun Kim; Vidyashankara Iyer; Sangeeta B Joshi; David B Volkin; C Russell Middaugh
Journal:  Protein Sci       Date:  2012-09-17       Impact factor: 6.725

2.  Aluminum hydroxide influences not only the extent but also the fine specificity and functional activity of antibody responses to tick-borne encephalitis virus in mice.

Authors:  Juergen Zlatkovic; Georgios Tsouchnikas; Johanna Jarmer; Christian Koessl; Karin Stiasny; Franz X Heinz
Journal:  J Virol       Date:  2013-09-04       Impact factor: 5.103

Review 3.  Polyionic vaccine adjuvants: another look at aluminum salts and polyelectrolytes.

Authors:  Bradford S Powell; Alexander K Andrianov; Peter C Fusco
Journal:  Clin Exp Vaccine Res       Date:  2015-01-30

Review 4.  Optimizing the utilization of aluminum adjuvants in vaccines: you might just get what you want.

Authors:  Harm HogenEsch; Derek T O'Hagan; Christopher B Fox
Journal:  NPJ Vaccines       Date:  2018-10-10       Impact factor: 7.344

5.  Rapid Developability Assessments to Formulate Recombinant Protein Antigens as Stable, Low-Cost, Multi-Dose Vaccine Candidates: Case-Study With Non-Replicating Rotavirus (NRRV) Vaccine Antigens.

Authors:  Nishant Sawant; Kawaljit Kaur; David A Holland; John M Hickey; Sanjeev Agarwal; Joseph R Brady; Neil C Dalvie; Mary Kate Tracey; M Lourdes Velez-Suberbie; Stephen A Morris; Shaleem I Jacob; Daniel G Bracewell; Tarit K Mukhopadhyay; Kerry R Love; J Christopher Love; Sangeeta B Joshi; David B Volkin
Journal:  J Pharm Sci       Date:  2020-12-05       Impact factor: 3.534

6.  Physicochemical Characterization Cascade of Nanoadjuvant-Antigen Systems for Improving Vaccines.

Authors:  Giuditta Guerrini; Antonio Vivi; Sabrina Gioria; Jessica Ponti; Davide Magrì; Arnd Hoeveler; Donata Medaglini; Luigi Calzolai
Journal:  Vaccines (Basel)       Date:  2021-05-21

7.  Mechanism of immunopotentiation and safety of aluminum adjuvants.

Authors:  Harm Hogenesch
Journal:  Front Immunol       Date:  2013-01-10       Impact factor: 7.561

8.  Development of Streptococcus pneumoniae Vaccines Using Live Vectors.

Authors:  Shifeng Wang; Roy Curtiss
Journal:  Vaccines (Basel)       Date:  2014-01-07

Review 9.  Unraveling the enigma: elucidating the relationship between the physicochemical properties of aluminium-based adjuvants and their immunological mechanisms of action.

Authors:  Emma Shardlow; Matthew Mold; Christopher Exley
Journal:  Allergy Asthma Clin Immunol       Date:  2018-11-07       Impact factor: 3.406

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.